← Leaderboards
Mario Tomas Philipp
Tulane University Of Louisiana
$11,469,177
Attributed
$12,783,520
Total exposure
83
Grants
51
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$12,325,939 · 82
CDC$457,581 · 1
By mechanism
R01$7,943,478 · 3
P51$4,382,461 · 79
U01$457,581 · 1
Top collaborators
- Ian Marriott5 shared
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Karol Sestak$5,154,708
Others in their field
Top investigators on “Funding”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,479,940,681
- Leonard Freedman · Leidos Biomedical Research, Inc.$968,195,877
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Jeffrey P Krischer · University Of South Florida$358,470,093
Research focus
FundingGrantInflammationMacaca MulattaSourceResearch PersonnelResourcesUnited States National Institutes Of HealthBorrelia BurgdorferiLyme DiseasePrimatesInstitutionCellsComputer Retrieval Of Information On Scientific Projects DatabaseInflammatoryNeuraxisNeuronsResponseNeurogliaInflammatory ResponseOrder SpirochaetalesMicrogliaCytokineResearch Study
Grant awards (121)
Pilot$277,943
P51 · FY2019 · OD · contact PI
Education and Training$80,385
P51 · FY2019 · OD · contact PI
Scientific Unit: Division Bacteriology and Parasitology Office of the Chair$39,612
P51 · FY2019 · OD · contact PI
Core Services: Division of Bacteriology and Parasitology, Diagnostic Parasitology Core$24,630
P51 · FY2019 · OD · contact PI
Pilot$277,943
P51 · FY2018 · OD · contact PI
Education and Training$80,385
P51 · FY2018 · OD · contact PI
Scientific Unit: Division Bacteriology and Parasitology Office of the Chair$39,612
P51 · FY2018 · OD · contact PI
Core Services: Division of Bacteriology and Parasitology, Diagnostic Parasitology Core$24,630
P51 · FY2018 · OD · contact PI
Substance P exacerbation of CNS inflammation$432,291
R01 · FY2016 · NS
Substance P exacerbation of CNS inflammation$438,417
R01 · FY2015 · NS
Substance P exacerbation of CNS inflammation$456,817
R01 · FY2014 · NS
Lyme neuroborreliosis pathogenesis in the rhesus monkey$419,460
R01 · FY2014 · NS · contact PI
Substance P exacerbation of CNS inflammation$630,904
R01 · FY2013 · NS
Lyme neuroborreliosis pathogenesis in the rhesus monkey$398,061
R01 · FY2013 · NS · contact PI
Substance P exacerbation of CNS inflammation$670,258
R01 · FY2012 · NS
Lyme neuroborreliosis pathogenesis in the rhesus monkey$463,640
R01 · FY2012 · NS · contact PI
Lyme neuroborreliosis pathogenesis in the rhesus monkey$566,512
R01 · FY2011 · NS · contact PI
PATHOGENESIS OF LYME NEUROBORRELIOSIS: STUDIES EX VIVO & IN VIVO$37,186
P51 · FY2011 · RR · contact PI
A RHESUS MACAQUE MODEL OF STREPTOCOCCUS PNEUMONIAE CARRIAGE$37,186
P51 · FY2011 · RR · contact PI
TICK SALIVA INHIBITS INFLAMMATION IN MONOCYTES STIMULATED WITH B BURGDORFERI$37,186
P51 · FY2011 · RR · contact PI
PATHOGENESIS OF LYME NEUROBORRELIOSIS IN THE RHESUS MONKEY: STUDIES IN VITRO$37,186
P51 · FY2011 · RR · contact PI
DIAGNOSTIC PARASITOLOGY CORE$37,186
P51 · FY2011 · RR · contact PI
VECTOR-BORNE DISEASES CORE$37,186
P51 · FY2011 · RR · contact PI
Lyme neuroborreliosis pathogenesis in the rhesus monkey$597,877
R01 · FY2010 · NS · contact PI
CHARACTERIZATION OF A MORAXELLA SPECIES THAT CAUSES EPSTAXIS IN MACAQUES$61,801
P51 · FY2010 · RR · contact PI
TICK SALIVA INHIBITS INFLAMMATION IN MONOCYTES STIMULATED WITH B BURGDORFERI$61,801
P51 · FY2010 · RR · contact PI
PATHOGENESIS OF LYME NEUROBORRELIOSIS IN THE RHESUS MONKEY: STUDIES IN VITRO$61,801
P51 · FY2010 · RR · contact PI
DIAGNOSTIC PARASITOLOGY CORE$61,801
P51 · FY2010 · RR · contact PI
VECTOR-BORNE DISEASES CORE$61,801
P51 · FY2010 · RR · contact PI
PATHOGENESIS OF LYME NEUROBORRELIOSIS: STUDIES EX VIVO & IN VIVO$61,801
P51 · FY2010 · RR · contact PI
Lyme neuroborreliosis pathogenesis in the rhesus monkey$81,685
R01 · FY2009 · NS · contact PI
VECTOR-BORNE DISEASES CORE$57,967
P51 · FY2009 · RR · contact PI
DOXYCYCLINE AND MINOCYCLINE INHIBIT INFLAMMATORY RESPOSES TO B BURGDORFERI$57,967
P51 · FY2009 · RR · contact PI
TICK SALIVA INHIBITS INFLAMMATION IN MONOCYTES STIMULATED WITH B BURGDORFERI$57,967
P51 · FY2009 · RR · contact PI
CLOSING THE PHENOTYPIC GAP BETWEEN TRANSFORMED AND UNTRANSFORMED NEURONS$57,967
P51 · FY2009 · RR · contact PI
PATHOGENESIS OF LYME NEUROBORRELIOSIS IN THE RHESUS MONKEY: STUDIES IN VITRO$57,967
P51 · FY2009 · RR · contact PI
PATHOGENESIS OF LYME NEUROBORRELIOSIS: STUDIES EX VIVO & IN VIVO$57,967
P51 · FY2009 · RR · contact PI
TOLL-LIKE RECEPTORS IN LYME NEUROBORRELIOSIS$57,967
P51 · FY2009 · RR · contact PI
A RHESUS MODEL FOR COLONIZATION AND DISEASE WITH BACTERIA OF THE GENUS MORAXELLA$34,816
P51 · FY2009 · RR · contact PI
Lyme neuroborreliosis pathogenesis in the rhesus monkey$420,143
R01 · FY2008 · NS · contact PI
THE C6 PEPTIDE HAS EPITOPES INACCESSIBLE TO ANTIBODY ON THE VLSE MOLECULE$24,103
P51 · FY2008 · RR · contact PI
TICK SALIVA INHIBITS INFLAMMATION IN MONOCYTES STIMULATED WITH B BURGDORFERI$24,103
P51 · FY2008 · RR · contact PI
CLOSING THE PHENOTYPIC GAP BETWEEN TRANSFORMED AND UNTRANSFORMED NEURONS$24,103
P51 · FY2008 · RR · contact PI
B BURGDORFERI VLSE IN RABBITS$24,103
P51 · FY2008 · RR · contact PI
PATHOGENESIS OF LYME NEUROBORRELIOSIS IN THE RHESUS MONKEY: STUDIES IN VITRO$24,103
P51 · FY2008 · RR · contact PI
PATHOGENESIS OF LYME NEUROBORRELIOSIS IN THE RHESUS MONKEY: STUDIES EX VIVO$24,103
P51 · FY2008 · RR · contact PI
VECTOR-BORNE DISEASES CORE$24,103
P51 · FY2008 · RR · contact PI
TOLL-LIKE RECEPTORS IN LYME NEUROBORRELIOSIS$24,103
P51 · FY2008 · RR · contact PI
Lyme neuroborreliosis pathogenesis in the rhesus monkey$458,834
R01 · FY2007 · NS · contact PI
Pathogenesis of Lyme Borreliosis in the Rhesus Monkey$222,924
U01 · FY2007 · CI · contact PI
PATHOGENESIS OF LYME NEUROBORRELIOSIS IN THE RHESUS MONKEY: STUDIES IN VITRO$30,392
P51 · FY2007 · RR · contact PI
B BURGDORFERI VLSE IN RABBITS$30,392
P51 · FY2007 · RR · contact PI
C6 TEST IN RST2-INFECTED HOSTS$30,391
P51 · FY2007 · RR · contact PI
TOLL-LIKE RECEPTORS IN LYME NEUROBORRELIOSIS$30,391
P51 · FY2007 · RR · contact PI
VECTOR-BORNE DISEASES CORE$30,391
P51 · FY2007 · RR · contact PI
PATHOGENESIS OF LYME NEUROBORRELIOSIS IN THE RHESUS MONKEY: STUDIES EX VIVO$30,391
P51 · FY2007 · RR · contact PI
THE RELATIVE CONTRIBUTION OF C6 EPITOPE(S) TO THE ANTIBODY RESPONSE TO VLSE$30,391
P51 · FY2007 · RR · contact PI
THE C6 TEST IN PATIENTS WITH SOUTHERN TICK-ASSOCIATED RASH ILLNESS (STARI)$30,391
P51 · FY2007 · RR · contact PI
Lyme neuroborreliosis pathogenesis in the rhesus monkey$464,366
R01 · FY2006 · NS · contact PI
Pathogenesis of Lyme Borreliosis in the Rhesus Monkey$234,657
U01 · FY2006 · CI · contact PI
THE RELATIVE CONTRIBUTION OF C6 EPITOPE(S) TO THE ANTIBODY RESPONSE TO VLSE$30,971
P51 · FY2006 · RR · contact PI
TOLL-LIKE RECEPTORS IN LYME NEUROBORRELIOSIS$30,971
P51 · FY2006 · RR · contact PI
EVALUATION OF A QUANTITATIVE C6 AB TEST IN ADULTS WITH 2 EPISODES OF EM$30,971
P51 · FY2006 · RR · contact PI
INFECTIVITY OF THE TRANSFORMABLE BBE02-, LP56- MUTANT OF B BURGDORFERI$30,971
P51 · FY2006 · RR · contact PI
THE C6 TEST IN PATIENTS WITH SOUTHERN TICK-ASSOCIATED RASH ILLNESS (STARI)$30,971
P51 · FY2006 · RR · contact PI
VECTOR-BORNE DISEASES CORE$30,971
P51 · FY2006 · RR · contact PI
EXPERIMENTAL INFECTION OF RHESUS MACAQUES WITH STREPTOCOCCUS PNEUMONIAE$30,971
P51 · FY2006 · RR · contact PI
DECLINE IN C6 AB IN SUCCESSFULLY TREATED LYME DISEASE PATIENTS$30,971
P51 · FY2006 · RR · contact PI
PATHOGENESIS OF LYME NEUROBORRELIOSIS IN THE RHESUS MONKEY$30,971
P51 · FY2006 · RR · contact PI
Lyme neuroborreliosis pathogenesis in the rhesus monkey$492,677
R01 · FY2005 · NS
PATHOGENESIS OF LYME BORRELIOSIS IN RHESUS MONKEY$37,662
P51 · FY2005 · RR
ANTIBIOTIC TREATMENT OF CHRONIC LYME DISEASE IN RHESUS MONKEY$37,662
P51 · FY2005 · RR
C6 TEST IN PATIENTS WITH A HISTORY OF LYME DISEASE$37,662
P51 · FY2005 · RR
LIPOPROTEINS MEDIATE THE PROINFLAMMATORY RESPONSE ELICITED BY BRUCELLA ABORTUS$37,662
P51 · FY2005 · RR
EVALUATION OF C6 PEPTIDE ELISA IN DOGS VACCINATED WITH RECOMBINANT OSPA VACCINE$37,662
P51 · FY2005 · RR
A NOVEL 3-DIMENSIONAL CELL CULTURE APPROACH FOR STUDYING NEUROBORRELIOSIS$37,662
P51 · FY2005 · RR
AN IMMUNE EVASION MECHANISM FOR SPIROCHETAL PERSISTENCE IN LYME BORRELIOSIS$37,662
P51 · FY2005 · RR
A POSSIBLE TEST FOR ELIMINATION OF A BORRELIA BURGDORFERI INFECTION$37,662
P51 · FY2005 · RR
Pathogenesis of Lyme Borreliosis in the Rhesus Monkey$0
U01 · FY2005 · CI
Lyme neuroborreliosis pathogenesis in the rhesus monkey$467,536
R01 · FY2004 · NS
PATHOGENESIS OF LYME BORRELIOSIS IN RHESUS MONKEY$47,161
P51 · FY2004 · RR
C6 PEPTIDE ELISA IN DOGS VACCINATED WITH OSPA VACCINE$46,011
P51 · FY2004 · RR
C6-TESTING IS SENSITIVE AND SPECIFIC FOR LYME DISEASE$46,011
P51 · FY2004 · RR
IXODES SCAPULARIS TICKS FROM LOUISIANA CAN TRANSMIT LYME DISEASE$46,011
P51 · FY2004 · RR
OSPA LIPIDATION AND VACCINATION OF TLR-2-DEFICIENT MICE$46,011
P51 · FY2004 · RR
3-DIMENSIONAL CELL CULTURE APPROACH FOR NEUROBORRELIOSIS$46,011
P51 · FY2004 · RR
LYME SPIROCHETAL PERSISTENCE: IMMUNE EVASION MECHANISM$46,011
P51 · FY2004 · RR
A TEST FOR ELIMINATION OF BORRELIA BURGDORFERI INFECTION$46,011
P51 · FY2004 · RR
A DNA VACCINE TO PREVENT TRANSMISSION OF HUMAN MALARIA$46,011
P51 · FY2004 · RR
ANTIBIOTICS FOR CHRONIC LYME DISEASE IN RHESUS MONKEYS$46,009
P51 · FY2004 · RR
Pathogenesis of Lyme Borreliosis in the Rhesus Monkey$0
U01 · FY2004 · CI
'Lyme disease: A possible test for cure$148,000
R01 · FY2003 · AI
ANTIBIOTIC TREATMENT OF CHRONIC LYME DISEASE IN RHESUS MONKEY$53,498
P51 · FY2003 · RR
PATHOGENESIS OF LYME BORRELIOSIS IN RHESUS MONKEY$53,199
P51 · FY2003 · RR
A DNA VACCINE TO PREVENT TRANSMISSION OF HUMAN MALARIA$53,199
P51 · FY2003 · RR
EVALUATION OF THE C6 PEPTIDE ELISA IN VACCINATED INDIVIDUALS$53,199
P51 · FY2003 · RR
AN IMMUNE EVASION MECHANISM FOR SPIROCHETAL PERSISTENCE IN LYME BORRELIOSIS$53,199
P51 · FY2003 · RR
ASSESSMENT OF THE NASOPHARYNGEAL BACTERIAL FLORA OF RHESUS MACAQUES$53,199
P51 · FY2003 · RR
DIAGNOSIS OF LYME DISEASE USING THE ANTI-C6 SEROLOGIC TEST$53,199
P51 · FY2003 · RR
A POSSIBLE TEST FOR ELIMINATION OF A BORRELIA BURGDORFERI INFECTION$53,199
P51 · FY2003 · RR
'Lyme disease: A possible test for cure$160,000
R01 · FY2002 · AI
'Lyme disease: A possible test for cure$24,000
R01 · FY2002 · AI
IMMUNODOMIN &CONSERV REGION: VLSE CASSETTE SEGMENT:SURFACE ANTIGEN:LYME DISEASE$0
P51 · FY2002 · RR
REAGENTS FOR IMPROVED DIAGNOSTIC SEROLOGY OF LYME DISEASE$0
P51 · FY2002 · RR
REGULATION OF LIPOPROTEIN GENE EXPRESSION IN B BURGDORFERI : LYME DISEASE$0
P51 · FY2002 · RR
PATHOGENESIS OF LYME BORRELIOSIS IN RHESUS MONKEY$0
P51 · FY2002 · RR
ANTIBIOTIC TREATMENT OF CHRONIC LYME DISEASE IN RHESUS MONKEY$0
P51 · FY2002 · RR
OSPA, LYME DISEASE VACCINE ANTIGEN, IN BIOLOGY OF BORRELIA BURGDORFERI$0
P51 · FY2002 · RR
'Lyme disease: A possible test for cure$152,000
R01 · FY2001 · AI
PATHOGENESIS OF LYME BORRELIOSIS IN RHESUS MONKEY$0
P51 · FY2001 · RR
OSPA, LYME DISEASE VACCINE ANTIGEN, IN BIOLOGY OF BORRELIA BURGDORFERI$0
P51 · FY2001 · RR
IMMUNODOMIN &CONSERV REGION: VLSE CASSETTE SEGMENT:SURFACE ANTIGEN:LYME DISEASE$0
P51 · FY2001 · RR
REAGENTS FOR IMPROVED DIAGNOSTIC SEROLOGY OF LYME DISEASE$0
P51 · FY2001 · RR
REGULATION OF LIPOPROTEIN GENE EXPRESSION IN B BURGDORFERI : LYME DISEASE$0
P51 · FY2001 · RR
ANTIBIOTIC TREATMENT OF CHRONIC LYME DISEASE IN RHESUS MONKEY$0
P51 · FY2001 · RR
PATHOGENESIS OF LYME BORRELIOSIS IN RHESUS MONKEY$99,946
P51 · FY2000 · RR
REAGENTS FOR IMPROVED DIAGNOSTIC SERIKIGY OF LYME DISEASE$99,946
P51 · FY2000 · RR
DNA VACCINE TO PREVENT TRANSMISSION OF HUMAN MALARIA$99,946
P51 · FY2000 · RR
IMMUNODOMINANT CONSERVED VLSE REGION, VARIANT SURFACE ANTIGEN OF B BURGDORFERI$99,946
P51 · FY2000 · RR
REGULATION OF LIPOPROTEIN GENE EXPRESSION IN BORRELIA BURGDORFERI$99,946
P51 · FY2000 · RR
ANTIBIOTIC TREATMENT OF CHRONIC LYME DISEASE IN RHESUS MONKEYS$99,946
P51 · FY2000 · RR